Literature DB >> 8144868

Two cases of Graves' disease with presentation of unilateral diffuse uptake of radioisotopes.

S Sakata1, Y Fuwa, S Goto, M Fukui, H Yuasa, H Takuno, H Sarui, I Matsui, T Ogawa, N Sasano.   

Abstract

We present two cases of Graves' disease whose initial thyroidal scintiscan with 99mTcO4- (Case 1) and 123I (Case 2) showed unilateral diffuse uptake of radioisotopes. Initial diagnosis was possibility of malignancy in Case 1 and Graves' disease or Plummer's disease in Case 2. Both cases underwent right hemithyroidectomy. Histopathology of the resected thyroid gland in both showed hyperplastic columnar epithelium and infiltrative lymphocytes which was compatible with Graves' disease. Twenty seven (Case 1) and eight months (Case 2) after operation, both presented with thyrotoxic symptoms associated with enlarged left lobe, increased serum free thyroid hormone concentrations, suppressed TSH concentration, increased thyroidal 123I uptake in the remaining left lobe, and positive thyrotropin receptor antibodies. Both cases were successfully treated with methimazole. It was concluded that initial radioisotope uptake as well as scintigram in rare subgroup of patients with Graves' disease could be similar with that of non-autoimmune autonomous goiter (Plummer's disease).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8144868     DOI: 10.1007/BF03348954

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  12 in total

Review 1.  Immune mechanisms in Graves' disease.

Authors:  K D Burman; J R Baker
Journal:  Endocr Rev       Date:  1985       Impact factor: 19.871

2.  Optimization and clinical assessment of a radioreceptor assay for thyrotropin-binding inhibitor immunoglobulins.

Authors:  J Konishi; K Kasagi; Y Iida; T Kousaka; T Misaki; K Arai; Y Tokuda; K Torizuka
Journal:  Endocrinol Jpn       Date:  1987-02

3.  Comparative thyroid uptake studies with 131 I and 99m TcO 4 - .

Authors:  G Burke; A Halko; G E Silverstein; M Hilligoss
Journal:  J Clin Endocrinol Metab       Date:  1972-04       Impact factor: 5.958

4.  Long-acting thyroid stimulator (LATS) in toxic nodular goitre, toxic adenoma and Graves' disease.

Authors:  B A Lamberg; A Gordin; M Viherkoski; G Kvist
Journal:  Acta Endocrinol (Copenh)       Date:  1969-10

5.  Autoimmune-resistance in Graves' disease tissues indication of a structural and functional heterogenicity.

Authors:  H W Müller-Gärtner; C Schneider; S Schröder
Journal:  Acta Endocrinol (Copenh)       Date:  1986-10

6.  Toxic multinodular goiter: a variant of autoimmune hyperthyroidism.

Authors:  Z Kraiem; B Glaser; M Yigla; J Pauker; O Sadeh; M Sheinfeld
Journal:  J Clin Endocrinol Metab       Date:  1987-10       Impact factor: 5.958

7.  Hyperthyroid Graves' disease without detectable thyrotropin receptor antibodies.

Authors:  A Ilicki; A Gamstedt; F A Karlsson
Journal:  J Clin Endocrinol Metab       Date:  1992-05       Impact factor: 5.958

8.  Thyroid-stimulating immunoglobulins do not cause non-autonomous, autonomous, or toxic multinodular goitres.

Authors:  J H Bolk; J W Elte; J K Bussemaker; A Haak; D van der Heide
Journal:  Lancet       Date:  1979-07-14       Impact factor: 79.321

9.  Morphologic and functional substrate of thyrotoxicosis caused by nodular goiters.

Authors:  H Studer; H R Hunziker; C Ruchti
Journal:  Am J Med       Date:  1978-08       Impact factor: 4.965

10.  Do thyroid-stimulating immunoglobulins cause non-toxic and toxic multinodular goitre?

Authors:  R S Brown; I M Jackson; S L Pohl; S Reichlin
Journal:  Lancet       Date:  1978-04-29       Impact factor: 79.321

View more
  2 in total

1.  Hyperthyroidism of Graves' disease: evidence for only unilateral involvement of the thyroid gland in a 31-year-old female patient.

Authors:  H P Dimai; S Ramschak-Schwarzer; S Lax; R W Lipp; G Leb
Journal:  J Endocrinol Invest       Date:  1999-03       Impact factor: 4.256

2.  Unilateral Graves' Disease.

Authors:  Vnssvams D Mahalakshmi; Sapana Bothra; Aromal Chekavar; Mallika Dhanda; Sabaretnam Mayilvaganan
Journal:  Indian J Nucl Med       Date:  2019 Oct-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.